Literature DB >> 22728614

Insulin pump treatment in children and adolescents with type 1 diabetes.

S Hofer1, D Meraner, J Koehle.   

Abstract

Within children and adolescents with type 1 diabetes insulin pump treatment is of increasing interest. Frequency of insulin pump therapy shows a rapid and steep increase in toddlers and young children. Insulin pumps allow a close to physiologic insulin delivery due to basal rates programmed over 24 hours with circadian rhythms taken into account. Furthermore, another advantage of technical devices as insulin pumps is the application of extremely small amounts of insulin, as needed in very young children, with the possibility of titration of infusion rates down to 0.01E/h. Dawn Phenomenon and hypoglycemic events are main indications for insulin pump treatment in children and adolescents. A significant reduction of severe hypoglycemia, especially nocturnal hypoglycemia was shown, whereas a reduction of HbA1c and an improvement of metabolic control has been reported in short term and in some but not all long term studies. Ketoacidosis rate did not increase in insulin pump therapy. Complications due to continuous subcutaneous insulin infusion, like local infections and dermatological changes are frequent but were not associated with glycemic control and did not lead to discontinuation of insulin pump treatment. Pump discontinuation rate in general is low, varying from 1% in very young children up to 6% in pubertal adolescent girls. Insulin pump treatment was shown to be safe and efficient and the simplicity of handling the devices as well as an improvement of quality of life may explain the rapid increase of pump treatment in young children and adolescents with type 1 diabetes.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22728614

Source DB:  PubMed          Journal:  Minerva Pediatr        ISSN: 0026-4946            Impact factor:   1.312


  4 in total

1.  Home Visits for Children and Adolescents with Uncontrolled Type 1 Diabetes.

Authors:  Stephanie S Crossen; James P Marcin; Lihong Qi; Hadley S Sauers-Ford; Allison M Reggiardo; Shelby T Chen; Victoria A Tran; Nicole S Glaser
Journal:  Diabetes Technol Ther       Date:  2019-09-18       Impact factor: 6.118

2.  Changing costs of type 1 diabetes care among US children and adolescents.

Authors:  Stephanie Crossen; Guibo Xing; Jeffrey S Hoch
Journal:  Pediatr Diabetes       Date:  2020-03-02       Impact factor: 4.866

3.  20 Years of Pediatric Benchmarking in Germany and Austria: Age-Dependent Analysis of Longitudinal Follow-Up in 63,967 Children and Adolescents with Type 1 Diabetes.

Authors:  Barbara Bohn; Beate Karges; Christian Vogel; Klaus-Peter Otto; Wolfgang Marg; Sabine E Hofer; Elke Fröhlich-Reiterer; Martin Holder; Michaela Plamper; Martin Wabitsch; Wolfgang Kerner; Reinhard W Holl
Journal:  PLoS One       Date:  2016-08-17       Impact factor: 3.240

4.  Use of continuous subcutaneous insulin infusion in children and adolescents with type 1 diabetes mellitus: a systematic mapping review.

Authors:  Carolina Spinelli Alvarenga; Rebecca Ortiz La Banca; Rhyquelle Rhibna Neris; Valéria de Cássia Sparapani; Miguel Fuentealba-Torres; Denisse Cartagena-Ramos; Camila Lima Leal; Marcos Venicio Esper; Lucila Castanheira Nascimento
Journal:  BMC Endocr Disord       Date:  2022-02-19       Impact factor: 2.763

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.